Credo Slides 19% After a Beat, and Analysts Still See $300

Credo shares fell nearly 19% after the company reported triple-digit revenue growth and its eighth consecutive earnings beat, and the stock was quoted at 168.24, up 0.29%, as of 18:03 GMT on Sept. 9, 2026, while some analysts maintain price targets above $300.

Credo (CRDO) did what a high-multiple semiconductor company is supposed to do. It grew revenue at a triple-digit rate. It beat consensus for the eighth quarter in a row. Then the stock fell nearly 19%.

That gap between the reported numbers and the market's reaction is the whole story. Investors were not marking down what Credo earned. They were marking down what they had already paid for what Credo might earn next. When a stock is priced for a long run of acceleration, a beat is the baseline, not the reward, and anything short of a fresh upgrade to the trajectory reads as a deceleration.

By midweek the panic had at least stopped compounding. Credo traded at 168.24 as of 18:03 GMT on Sept. 9, 2026, up 0.29% against a prior close of 167.75, having swung between 164.19 and 173.24 during the session. That is a wide intraday band for a stock trying to find a floor, and it tells you the shareholder base is still turning over.

Why a beat can still cost you a fifth of your market value

Triple-digit revenue growth is an extraordinary number in semiconductors, and it is also a number that contains its own risk. Growth at that rate is almost always concentrated: a handful of hyperscale customers ordering ahead of a build-out, with orders that arrive in lumps rather than in a smooth curve. The market prices the curve. The company delivers the lumps.

An eighth consecutive beat compounds the problem rather than solving it. A streak that long trains buy-side models to assume the guide is conservative and the real number will land above it. Once that assumption is embedded in the share price, the company has to beat its own beat to hold the line. Guidance that merely looks solid then functions as a downgrade, and the de-rating happens in a single session — which is roughly what a near-19% drop after good results looks like.

The mechanics matter for anyone holding the stock. A move of that size in one day is rarely fundamental analysts changing their minds in real time. It is momentum funds, systematic strategies and options hedging unwinding a crowded position at the same moment. The fundamental view arrives afterwards, in the notes, and it is frequently far less dramatic than the tape.

The $300 case and what it has to assume

Which is where the sell side comes in. Analysts still carry price targets above $300 on Credo, according to 24/7 Wall St — targets that were not withdrawn when the stock cracked. Measured against the 168.24 quote, a $300 target implies roughly 78% appreciation from here, an illustrative calculation on the two figures rather than a forecast.

Targets that wide of the market price rest on a specific chain of assumptions, and it is worth naming them rather than taking the number at face value:

• The growth rate persists, not just the growth. Triple-digit expansion has to hand off to a still-high rate rather than a cliff, which requires the current customer set to keep ordering and new ones to arrive.
• Content per system rises. Bull cases in connectivity silicon generally assume the company sells more of its product into each rack generation, not simply more racks.
• The multiple survives. A target far above spot usually needs the market to keep paying a premium valuation. If the multiple compresses even as earnings grow, the price can stall.
• Concentration does not become a liability. A single large customer shifting to a competitor or to in-house silicon is the fastest route to breaking the model.

None of that makes the $300 view wrong. It does mean the target and the 19% drop are answers to different questions. The target is about the earnings power two or three years out. The selloff was about what the next quarter is worth to a leveraged holder today.

A jumpy tape gives the drop no cover

The broad market offered no excuse for the move and no help in absorbing it. The S&P 500, via SPY, sat at $763.16, down 0.37% from a $765.96 prior close, as of 18:03 GMT on Sept. 9. The Nasdaq 100 tracker QQQ was at $716.74, off 0.23%, and the Dow 30 proxy DIA at $524.98, down 0.58%. Those are ordinary drifting-lower sessions. Credo's decline was company-specific, and it happened in a market that was not in the mood to buy dips aggressively.

That backdrop is part of the read-through for the rest of the AI connectivity and networking complex. When the market punishes a triple-digit grower for guidance rather than results, every other name trading on the same forward multiple is on notice. The bar has moved from "beat" to "beat and raise convincingly."

What to track from here

The useful signals over the coming weeks are narrow and observable. First, whether Credo can hold above the low end of its post-results range — the 164.19 area marked out on Sept. 9 — or whether each rally attempt gets sold. Second, whether the sell side actually maintains those $300-plus targets in writing after the dust settles, or quietly trims them, which is the tell that the fundamental view has changed rather than just the positioning. Third, customer disclosure: any detail on whether revenue is broadening across buyers or tightening around one.

For long-term holders, an eight-quarter beat streak and triple-digit growth are not the profile of a business in trouble. For anyone who bought the momentum, the lesson is older than AI: when the price already assumes the good news, the good news is not enough.

Frequently asked questions

Why did Credo stock fall if it beat earnings?

Credo reported triple-digit revenue growth and its eighth straight earnings beat, yet shares dropped nearly 19%. In high-multiple semiconductor names, a beat is already assumed in the price. Investors react to the forward guidance and the trajectory it implies, so results that merely meet elevated expectations can trigger a sharp de-rating in a single session.

Where is Credo stock trading now?

Credo was quoted at 168.24 as of 18:03 GMT on Sept. 9, 2026, up 0.29% from a prior close of 167.75. The intraday range that session ran from 164.19 to 173.24, a wide band that suggests the shareholder base was still turning over after the post-earnings decline.

What do analysts' $300 price targets on Credo assume?

Targets above $300 generally require the growth rate to persist rather than fall off sharply, content per system to rise as new hardware generations ship, the premium valuation multiple to hold, and customer concentration not to become a liability. Against the 168.24 quote, a $300 target implies roughly 78% upside, an illustrative figure rather than a forecast.

Is an eighth consecutive earnings beat a bullish sign?

It shows execution, but it also raises the bar. A long beat streak trains investors to assume management guides conservatively and will exceed its own numbers. Once that expectation is embedded in the share price, the company must beat its own implied beat to hold the valuation, which makes a solid quarter look disappointing.

Did the broader market cause Credo's drop?

No. On Sept. 9, 2026, SPY was at $763.16, down 0.37%, QQQ at $716.74, down 0.23%, and DIA at $524.98, down 0.58% — ordinary mild declines. A near-19% single-stock fall against that backdrop is company-specific, driven by positioning and guidance rather than a market-wide selloff.

What should investors watch next in Credo?

Three things: whether the stock holds above the low end of its post-results range near 164.19 or gets sold on every rally; whether analysts formally maintain their $300-plus targets or quietly trim them; and whether customer disclosure shows revenue broadening across more buyers rather than concentrating further.

Sources

• The Credo Selloff Could Be a Huge Buying Opportunity: Analysts Still See $300+. — 24/7 Wall St

Photo: Annushka Ahuja · Pexels Licence — source